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Abstract
Background: The polyamine system has been implicated in a number of psychiatric conditions, which display both
alterations in polyamine levels and altered expression of genes related to polyamine metabolism. Studies have identified
associations between genetic variants in spermidine/spermine N1-acetyltransferase (SAT1) and both anxiety and suicide,
and several polymorphisms appear to play important roles in determining gene expression.
Methodology/Principal Findings: We genotyped 63 polymorphisms, spread across four polyaminergic genes (SAT1,
spermine synthase (SMS), spermine oxidase (SMOX), and ornithine aminotransferase like-1 (OATL1)), in 1255 French-
Canadian individuals who have been followed longitudinally for 22 years. We assessed univariate associations with anxiety,
mood disorders, and attempted suicide, as assessed during early adulthood. We also investigated the involvement of gene-
environment interactions in terms of childhood abuse, and assessed internalizing and externalizing symptoms as
endophenotypes mediating these interactions. Overall, each gene was associated with at least one main outcome: anxiety
(SAT1, SMS), mood disorders (SAT1, SMOX), and suicide attempts (SAT1, OATL1). Several SAT1 polymorphisms displayed
disease-specific risk alleles, and polymorphisms in this gene were involved in gene-gene interactions with SMS to confer risk
for anxiety disorders, as well as gene-environment interactions between childhood physical abuse and mood disorders.
Externalizing behaviors demonstrated significant mediation with regards to the association between OATL1 and attempted
suicide, however there was no evidence that externalizing or internalizing behaviors were appropriate endophenotypes to
explain the associations with mood or anxiety disorders. Finally, childhood sexual abuse did not demonstrate mediating
influences on any of our outcomes.
Conclusions/Significance: These results demonstrate that genetic variants in polyaminergic genes are associated with
psychiatric conditions, each of which involves a set of separate and distinct risk alleles. As several of these polymorphisms
are associated with gene expression, these findings may provide mechanisms to explain the alterations in polyamine
metabolism which have been observed in psychiatric disorders.
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Introduction
Mood and anxiety disorders represent the two most common
forms of mental illness, and are associated with a wide range of
behavioural and somatic symptoms as well as substantial disability
and decreased quality of life [1]. Suicidal behaviors are closely, but
not exclusively, associated with both psychiatric disorders [2–5].
These behaviors, which comprise ideation, attempts, and com-
pleted suicide, are amongst the most devastating consequences of
psychiatric disorders, and account for over a million deaths
worldwide each year [6]. Over the years, the importance of
genetic factors in psychiatric disorders has become increasingly
apparent, with overall heritability rates for depressive disorders,
anxiety disorders, and suicide ranging between 30–50% [7–11],
involving both shared and distinct genetic vulnerabilities [12–15].
Substantial efforts have been put towards identifying genes and
pathways involved in the pathology and etiology of these
conditions as these both represent sites involved in conferring risk
for their development, as well as act as potential targets for
pharmaceutical treatments [16,17]. Although the substantial
evidence emerging from genetic, metabolic, and pharmacological
studies investigating these disorders has implicated the involve-
ment of monoaminergic neurotransmission, particularly the
serotonin and catecholamine systems, dysregulation of these
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15146systems is not sufficient to account for all aspects of the clinical
presentations or heritability associated with these disorders, and it
has become abundantly clear that additional systems are involved.
The polyamine system represents an important source for
neurobiological factors involved in mood disorders, anxiety
disorders, and suicide. In recent years, the majority of the focus
has been on its involvement in suicidal behaviours, yet
considerable research across the last three decades has pointed
towards roles for the polyamine system in several psychiatric
conditions, including schizophrenia, mood disorders, and anxiety
disorders, and particular emphasis has been placed on the
importance of this system in the physiological and behavioural
responses to stress [18].
The polyamines are ubiquitous aliphatic molecules, comprising
spermine,spermidine,putrescine,andagmatine,whichareinvolved
in a vast range of cellular functions, including cell cycle modulation,
scavenging reactive oxygen species, control of gene expression, and
possess important roles in neurotransmission through their
modulation of the functioning of cell-surface receptors, involvement
in intracellular signalling pathways, as well as their putative roles as
neurotransmitters [19,20]. Cellular levels of the polyamines are
extensively regulated through tight control of their biosynthesis,
catabolism, and transport, and much of the evidence for their
involvement in psychiatric conditions to date has revolved around
variations in the levels of the polyamines, as well as alterations in the
expression of genes involved in polyamine metabolism, including
spermidine/spermine N1-acetyltransferase (SAT1), spermine oxi-
dase (SMOX), spermine synthase (SMS), and ornithine amino-
transferase–like 1 (OATL1) [21–26]. Given the extensive molecular
functions of the polyamines, their precise roles in the etiology and
pathology of psychiatric disorders remain unclear, although
evidence from animal studies have suggested that at least some of
their antidepressant and anxiolytic effects involve modulation of
transmission through N-methyl-D-aspartate receptors, a2-adreno-
ceptors, imidazoline receptors, and serotonin receptors [18].
In spite of the strong evidence suggesting a role for the
polyamine system in depression, anxiety, and suicide, with recent
evidence indicating direct polyamine dysregulation in brain tissue
from individual who died by suicide [27], only a few studies have
investigated polyamine-related genes at the genetic level, all of
which have focused exclusively on promoter polymorphisms in
SAT1, the main rate-limiting enzyme in polyamine catabolism.
Three studies found significant associations: rs6526342 with
suicide [21], rs6151267 with suicide in depressed individuals
[28], and rs1960264 with anxiety [29]. However, another study
found no association between either rs6526342 or rs17286006 and
suicide [23], nor was rs1960264 found to be associated with
schizophrenia [30]. Interestingly, these polymorphisms are part of
a larger haplotype block which is associated with SAT1 expression
in the brain [31], thereby representing a link between genetic
variability and downstream functional consequences. To date, no
genetic studies have examined the relationships between poly-
morphisms in other polyamine-related genes and psychiatric
disorders.
The aim of the present study was to expand our understanding
of the relationship between polymorphisms in polyamine-related
genes and psychiatric disorders, in particular mood disorders,
anxiety disorders, and suicidal behaviours, as well as to investigate
the potential for epistasis between genetic risk factors, and to
identify variables which may influence the effects of genetics on
psychopathology. To this end, we genotyped a large number of
polymorphisms in several genes involved in polyamine metabolism
in a French-Canadian cohort which has been followed for over 20
years. During this time, substantial clinical and epidemiological
measures were collected, and a number of these were assessed as
potential mediators for our genetic associations. Given the
influence of environmental stressors on the polyamine system
[18,32] as well as consistent findings implicating early life adversity
in the development of psychiatric disorders [33–35], the influence
of childhood sexual and physical abuse was assessed. We also
investigated several personality measures, comprising externalizing
or internalizing behaviors, as endophenotypes for our main
outcomes. As our previous research investigating externalizing
and internalizing trajectories in young children (ages 6 to 12) did
not identify mediating effects with regards to mood disorders or
suicide attempts [36,37], in this study these symptoms were
investigated at an older age (adolescence).
Overall, we identified several genetic risk factors associated with
mood disorders, anxiety disorders, and suicidal behaviours, as well
as several clinical variables which mediate these effects.
Methods
Study Participants
Participants in this study were part of a larger cohort of French-
Canadians recruited in 1986–1987, then followed-up for over 20
years. A more detailed description of this cohort as well as the
assessment schedules is found in [34,36]. In brief, children were
recruited from francophone schools in Quebec at age 6, where
they were assessed through a variety of demographic, social and
behavioral measures in several waves, representing childhood,
mid-adolescence, early adulthood, and mid-adulthood. The initial
sample comprised 3017 children, of which 2000 were randomly
selected and are considered representative of the young French-
speaking population. DNA was collected from the 1255 respon-
dents among the initial sample. In the representative sample of
2000 subjects, there were no differences between the respondents
and nonrespondents for parental age at birth of first child,
maternal socioeconomic status, or proportion living with both
biological parents. As both family adversity (described below) and
gender were related to attrition in our previous studies in this
cohort [36], we used them to construct weights for multivariate
analyses. This study was approved by the institutional review
boards of the University of Montreal and McGill University.
Written informed consent was obtained from all subjects.
Measures
Genetic Factors. Single nucleotide polymorphisms (SNPs)
were selected from four polyamine-related genes: SAT1
(NM_002970), SMOX (NM_175839), SMS (NM_004595), and
OATL1 (NM_001006113). SNPs were located between 5 kb
upstream of the transcription start site to 5 kb downstream of the
end of the last exon. Common tag SNPs (minor allele frequencies
.5%) for each gene were selected using HapMap data for the
Utah residents with Northern and Western European ancestry
[38] and the multi-marker tagging procedure in Tagger (r
2.0.8)
[39]. Additional SNPs in the upstream regions were selected using
the NCBI, Pupa, and Ensembl databases. In total, 63 polyamine-
related SNPs were genotyped, as shown in Supplementary Table
S1. We also included 42 anonymous markers spread in non-coding
regions across the genome in order to detect population
stratification. Genotyping was performed using a 768-SNP
Illumina platform with a custom-designed GoldenGate panel.
Following genotyping, several quality control steps were
performed as described in [36]. Two SNPs (rs1535225 and
rs2238958) had call rates of less than 90% and were removed.
Environmental Factors. Among the overall study group, we
defined two subsamples through their exposure to physical (CPA)
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Subjects in the CPA group self-reported severe or very severe
physical abuse perpetrated by either parent, as assessed in the
Conflict Tactics Scales [40,41]. Childhood sexual abuse was
defined as incidences of sexual violence experienced before the age
of 18, and was assessed by self-report as described in [42].
The effects of family adversity were also assessed. As described
in [43], we computed a family adversity index based upon
maternal reports regarding: (1) family structure (two parent or
single), (2) educational level of both parents (or the parent with
whom the child was living), (3) occupational status of both parents
(or occupation of the parent with whom the child was living) based
on the Blishen’s occupational prestige scale [44] and, (4) mother’s
and father’s age at birth of the first child. Higher values
correspond to higher family adversity levels at the time when the
participants were approximately 6 years of age.
Mediators
Diagnostic Interview Schedule for Children (DIS-C)
[45]. Using the DIS-C, self-reports of hyperactivity-impulsivity
(8 symptoms), oppositional defiant disorder (9 symptoms), conduct
disorder (11 symptoms), generalized anxiety (18 symptoms), panic
disorder (13 symptoms), major depression (9 symptoms), and
dysthymia (6 symptoms) were assessed. A total externalizing-
disruptiveness score was obtained by summing the symptom
counts associated with hyperactivity-impulsivity, oppositional
defiant disorder, and conduct disorder (Cronbach alpha =0.77).
Two separate internalizing scores were generated: an internalizing-
anxiety score was calculated by summing generalized anxiety and
panic disorder symptoms (Cronbach alpha =0.93), while an
internalizing-depression score was generated by summing major
depression and dysthymia symptoms (Cronbach alpha =0.94). To
equally weight each disorder when calculating the total sum scores,
each count variable was transformed to range between 0 and 1 (by
dividing the total count by the maximum count after adding 1 as a
constant) before calculating the total sum score.
Covariates and Outcomes
Diagnostic Interview Schedule for Adults (DIS) [46]. This
schedule assesses mood (major depression, bipolar disorder and
dysthymia), anxiety (generalized anxiety, panic and phobias),
disruptive (i.e., antisocial personality), and substance abuse
disorders (abuse and/or dependence on drugs, alcohol and
nicotine) using DSM-III-R criteria. Mood and anxiety disorders
represented outcomes and, in addition, served together with
disruptive and substance abuse disorders and suicide attempts (see
below) as the covariate ‘‘history of psychopathology’’, following
previousresearch[36].Thiscountvariablesummarized thenumber
of diagnoses in each individual. For each of the main outcome
variables,theothertwooutcomeswerepart ofthiscount variable,in
addition to substance and disruptive disorders. By means of
controlling for the other disorders, any significant gene-outcome
relationship is independent of these potentially confounding effects.
The DIS was also used to provide information regarding parental
history of suicide attempts, anxiety, and mood disorders. If either
parent had a positive history for these control variables, the
respective history was coded as ‘1’, otherwise it was coded as ‘0’.
Suicide attempts. Suicide attempt status was based on both
adolescent and adult assessments. Adolescent history was obtained
from parental/adolescent responses to a question from the DIS-C
[45]: ‘Have you already attempted suicide?’ Either parental or self-
report was sufficient for a person to be classified as an attempter.
Adult suicide attempts were assessed with a question from the
Suicidal Intent Scale [47]: ‘Have you already attempted suicide?’
A positive attempt status was coded as ‘1’ and negative as ‘0’.
Statistical Approach
Population Stratification. Although the French Canadians
descended from a small number of individuals and displays a well-
known founder effect [48,49], we nonetheless felt it was necessary
to identify population outliers - individuals displaying significantly
different allele frequency distributions from the rest of the sample
[50]. We used the genotype log likelihood test statistic with a cut-
off of P=0.01, identifying 12 outliers, which were excluded from
subsequent analyses. All SNPs fulfilled Hardy-Weinberg
equilibrium.
Univariate analyses. We first investigated direct effects
exerted by SNPs and haplotypes on our main outcomes (suicide
attempts, mood disorders, and anxiety disorders). We also
postulated that CSA or CPA may create associations of genetic
variants with phenotypes only in subjects exposed to these
environments and, therefore screened for such moderating or
interaction effects by testing for associations of SNPs with the
phenotypes in the subsamples of subjects exposed to CSA or CPA.
Firstly, in order to identify redundant SNPs, we used the
squared correlations between each SNP to identify all groups of
SNPs with r
2.0.99, then selected only one SNP from within each
group of these perfectly correlated SNPs, yielding a set of 43 SNPs
which were retained for all further analyses. The patterns of
linkage disequilibrium between SNPs within each gene are shown
in Supplementary Figure S1, and the set of non-redundant SNPs
are displayed in Supplementary Table S1.
x
2-tests and Fisher’s exact tests, in conjunction with a false
detection rate (FDR) cutoff of #0.20, were used to identify
significant SNPs under allelic, recessive and dominant genetic
models with respect to the minor allele. For X-linked SNPs, males
were coded as homozygous when assessing recessive and dominant
models. The FDR attached to each P-value for suicide attempts in
the total sample as well as all analyses in the CSA and CPA
subsamples was estimated using the Efron [51] method imple-
mented in R. The Benjamini-Hochsberg [52] method was used to
compute FDRs for analyses of anxiety and depression in the total
sample. The Benjamini-Hochsberg method was employed for
these analyses as the empirical null distribution was heavily skewed
and did not fit a normal distribution, which is required to apply
the Efron method. SNPs with FDR corrected P-value #0.20 were
further tested in adjusted multivariate models.
We determined haplotype blocks within each gene in the total
sample using entropy.blocker [53] implemented in the R statistical
environment. Global association tests to haplotypes within each
haplotype block were performed for suicide, depression, and
anxiety. For SMOX, haplotype analyses were performed using the
function haplo.score [54] from the package haplo.stats, implemented
in R. Analyses for the X chromosome genes were performed using
UNPHASED [55]. The analysis of SMS haplotypes was more
complicated due to the large number of SNPs in the SMS
haplotype block. Firstly, we formed ten subgroups of strongly
correlated SNPs, then made three different selections of ten SNPs
by randomly picking one SNP in each subgroup. These three
selections were then analysed using UNPHASED.
Multivariate analyses. Using a series of regression-based
analyses adjusted for psychopathology, we retained all significant
SNPs in a given gene (P,0.05), and included them together in a
model across genes. We also tested if the results in the final models
changed if we applied weights adjusting for the probability of
remaining in the sample conditional on the variables related to
attrition: gender and family adversity. The expectation-
Polyamine Variants in Psychiatric Disorders
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values.
We analyzed two forms of moderating effects: gene-gene
interactions, and gene-environment interactions. Gene-gene
interactive effects were assessed in order to examine moderation
of the effects of polyaminergic loci on the three outcomes by other
polyaminergic loci. These interactions were performed between
pairs of SNPs, in separate genes, from among those that displayed
significant univariate associations to the three main outcomes. To
assess these effects, in each regression model, we included two of
the significant main effects from the univariate analyses as well as
their interaction term. Interactions were only assessed using SNPs
which were significant in the univariate analyses, and only
between SNPs of different genes. Each set of predictors was tested
with a logistic and an additive regression model. We examined
allelic–allelic, dominant–dominant, dominant–recessive, recessive–
dominant and recessive–recessive model combinations, depending
on the significant mode found on the univariate step. Specifically,
we conducted ten regressions (suicide attempts: 2, mood disorders:
0, anxiety disorders: 8) and empirically determined whether logistic
or additive link functions yielded a better fit to the data, resulting in
two highly correlated sets of regressions and a total of twenty tests.
We believe that the low statistical power to detect interaction effects
in field studies, as described by McClelland and Judd [56], also
applies to psychiatric and genetic studies. We therefore did not
employ Type-I Error protection for the gene-gene interaction tests.
Following similar procedures, we tested gene-environment interac-
tions to examine the moderation of the effects of childhoodabuse on
the associations of SNPs with any of the three outcomes. We
controlled for confounding effects of passive or evocative gene-
environment correlations by adjusting models for parental histories
of psychopathology, and by demonstrating that genotypes did not
influence the exposure to abuse. Post-hoc tests wereused to quantify
regression slopes and examine the statistical significance of
significant moderating effects [57]. Corrections for multiple testing
were not performed at this stage in the analyses, as these tests were
performed using only SNPs which passed our FDR criteria in the
CSA and CPA subsamples prior to the inclusion of covariates.
Power analyses for these tests withthe mood disorder phenotypeare
shown in Supplementary Tables S2 and S3. As the prevalence of
suicide attempts and anxiety disorders were higher than that of
mood disorders in the sample, greater power is expected for these
two phenotypes.
In the presence of covariates, count scores of externalizing and
internalizing disorders were investigated as endophenotypes
mediating the significant main effects identified in the final models
of suicide attempts, mood disorders, and anxiety disorders.
Specifically, mediation testing was performed to identify variables
which accounted for some or all of the associations between our
genotypes and main outcomes [58], and the significance of these
results was assessed using Sobel and Goodman tests.
Results
Sample
From the initial 1255 subjects, fourteen subjects with call rates
less than 95% were excluded, and 108 subjects were removed as
they displayed non-White ethnicity. Assessment for population
outliers identified 12 subjects displaying significantly different
allele frequencies than the remainder of the population. After
exclusions, the total analyzed sample consisted of 1121 (N=664,
59% female) individuals, as shown in Table 1. Overall, exposure to
CSA or CPA was significantly associated with higher rates of
suicide attempts, mood disorders, and anxiety disorders.
Univariate analyses
Our first objective was to determine if genetic variants within
these polyamine genes were associated with our main outcomes in
order to identify potential risk or protective factors involved in
suicide attempts, mood disorders, or anxiety disorders.
Individual SNPs. We first examined association of the 43
non-redundant SNPs with each of the three adult outcomes (mood
disorders, anxiety disorders, and suicide attempts) under allelic,
dominant, and recessive models. As shown in Table 2, two SAT1
and five SMS SNPs exhibited recessive modes of inheritance
regarding the prediction of anxiety disorders, while three SMS
SNPs were significant in the dominant model. These two SAT1
SNPs were also significantly associated with mood disorders, where
they exhibited a dominant mode of inheritance. Additionally, six
SNPs were found to be significantly associated with mood disorders
in the CPA subsample in the dominant mode. Finally, three SNPs,
including one in SAT1 and two in OATL1, were significantly
associated with suicide attempts. Additionally, the results of the
univariate analyses for the CSA subsample indicated no significant
links to any of the adult outcomes, ruling out gene X environment
interactions involving childhood sexual abuse.
Haplotypes. The haplotype block analysis revealed that each
gene was contained within a single haplotype block. Overall,
association tests between haplotypes from each of the genes and the
adult outcomes indicated that common haplotypes did not yield any
more information than individual SNPs on the association between
the studied genes and the phenotypes (not shown).
Multivariate analyses
Gene-gene and gene-environment interactions. Given
the extensive regulation of polyamine metabolism, we were next
interested in determining if genetic factors found within separate
genes (Table 2) may interact in conferring risk for psychiatric
disorders. We found no significant interactions for either mood
disorders or suicide attempts, as both the interaction terms
between the two SNPs in mood disorders, and the three significant
SNPs associated with suicide attempts, were not significant.
As there was a high correlation between two of the pairs of
SNPs that were significantly associated with anxiety disorders
(rs10521911 and rs6654100 in SMS: r
2=0.96; and rs6526342 and
rs3764885 in SAT1: r
2=0.86), we randomly dropped one of the
SNPs of each pair from the interaction analyses. We found a
significant interaction in the additive model including the main
effects and the interaction term of rs3764885 (SAT1) and
rs6654100 (SMS) with respect to anxiety disorders (x
2
(1)=6.25,
Table 1. Characteristics of the total sample and the
childhood sexual abuse (CSA) and childhood physical abuse
(CPA) subsamples with respect to the main outcomes.
Sample Suicide Attempts Mood Disorders Anxiety Disorders
N N (%)
x
2
(1 df) N (%)
x
2
(1 df) N (%)
x
2
(1 df)
Total 1121 117 (10%) 107 (10%) 239 (21%)
CSA 230 53 (23%)
*** 48.9 44 (19%)
*** 28.1 77 (33%)
*** 25.5
CPA 316 55 (17%)
*** 22.9 47 (15%)
*** 12.9 88 (28%)
*** 11.2
x
2 tests for the CSA and CPA subgroups were performed with respect to all
other subjects not within those subgroups.
N= number,
***=P,0.001.
doi:10.1371/journal.pone.0015146.t001
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heterozyosity for the G alleles in rs3764885 (SAT1) and in
rs6654100 (SMS) had an elevated risk for anxiety disorders. No
other interaction tests were significant for anxiety disorders.
Next, we tested whether the significant SNPs for mood disorders
found in the CPA subsample (Table 2) may yield significant gene-
environment interactions in the overall sample. We found a
significant interaction in the additive model including the main
effects and the interaction term of rs3764885 (SAT1) and CPA as
well as parental mood disorder (x
2
(1)=5.51, P=0.02). As depicted in
Figure 2, individuals with homo/heterozyosity for the G allele in
rs3764885 (SAT1) and who were CPA victims had elevated rates of
mood disorders. This gene-environment interaction was not
confounded by evocative gene-environment correlation as indicated
bya nonsignificant correlation between the SNP and CPA (P=0.75).
In terms of passive gene-environment correlations, parental mood
disorders were weakly associated with CPA (r
2=0.081, P=0.005).
No other gene-environment interactions were significant.
Main/mediating effects. Our final objective was to identify
SNPs that are uniquely associated with our main outcomes, along
with clinical variables which mediate these associations. The
results of the multivariate analyses of the main effects are depicted
in Table 3. Overall, the final logistic models explained approxi-
mately 18%, 14%, and 11% of the variance in mood disorders,
suicide attempts and anxiety disorders, respectively. Using an
equivalent of Cook’s statistic for logistic regression, outlier
diagnostics indicated no cases of extreme influence except, in the
analysis of anxiety, the combination formed by the reference
values of all variables. However, the latter represented the largest
group of subjects. Multicollinearity was unlikely, as the highest
correlation among our variables was r
2=10.8%. The final
estimates obtained with the EM missing-value imputation
method had narrower confidence intervals (CI) but were
otherwise similar to unimputed estimates. Weighting for gender
and family adversity did not change estimates of significance levels
or odds ratios (OR) (not shown).
Mood disorders. As mentioned above, rs3764885 and
rs6526342 were highly associated, and were the only SNPs that
were significant for the prediction of mood disorders in the overall
sample. Table 3 depicts the final additive model that included
Table 2. Significant univariate associations between
polyamine genes and adult outcomes in the total and
childhood physical abuse (CPA) samples.
Gene SNP FDR Mode
Affected
(%)
Unaffected
(%) Sample
Anxiety Disorders
SAT1
** rs6526342 0.14 recessive 0.221 0.234 Total
SAT1
** rs3764885 0.14 recessive 0.217 0.220 Total
SMS
* rs5951672 0.19 dominant 0.071 0.050 Total
SMS
* rs2040357 0.19 recessive 0.333 0.344 Total
SMS
* rs732946 0.19 dominant 0.064 0.042 Total
SMS
** rs5904598 0.14 recessive 0.262 0.310 Total
SMS
** rs10521911 0.16 recessive 0.171 0.214 Total
SMS
** rs5951676 0.14 dominant 0.071 0.046 Total
SMS
* rs5951678 0.19 recessive 0.243 0.260 Total
SMS
** rs6654100 0.14 recessive 0.167 0.210 Total
Mood Disorders
SAT1
** rs6526342 0.19 dominant 0.283 0.224 Total
SAT1
** rs3764885 0.19 dominant 0.262 0.214 Total
SAT1
A** rs6526342 0.02 dominant 0.305 0.211 CPA
SAT1
A** rs3764885 0.02 dominant 0.305 0.202 CPA
SAT1
* rs1894289 0.04 dominant 0.451 0.366 CPA
SMOX
A* rs1622950 0.04 dominant 0.596 0.459 CPA
SMOX
A* rs1765017 0.04 dominant 0.564 0.447 CPA
SMOX
A* rs6084657 0.14 dominant 0.596 0.489 CPA
Suicide Attempts
OATL1
A** rs11795513 0.007 dominant 0.400 0.330 Total
OATL1
* rs2249583 0.03 dominant 0.460 0.411 Total
SAT1
A* rs1894289 0.07 recessive 0.325 0.406 Total
False discovery rate (FDR) corrected P-values are shown for each association,
and the mode under which the significant effect is observed is indicated. The
percentage of affected and unaffected subjects carrying the minor allele is
indicated.
Aallelic test FDR also ,0.20.
P-values:
*=0.05–0.01 inclusive,
**=0.0099–0.001 inclusive,
***,0.001.
doi:10.1371/journal.pone.0015146.t002
Figure 1. Significant gene-gene interaction between rs3764885
(SAT1) and rs6654100 (SMS) for anxiety disorders.
doi:10.1371/journal.pone.0015146.g001
Figure 2. Significant gene-environment interaction between
rs3764885 (SAT1) and childhood physical abuse (CPA) for
mood disorders.
doi:10.1371/journal.pone.0015146.g002
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interaction model described above. We found no evidence for a
mediating effect of CSA, although there was a relationship
between CSA and mood disorders (r=0.10, P=0.0005), after
controlling for the covariate effects.
Suicide attempts. One SNP (OATL1, rs11795513) made a
statistically significant contribution to suicide attempts (OR=1.80)
independently of parental attempt (OR=3.52) and Axis I diagnoses
(OR=2.74). We found evidence for evocative gene-environment
correlation for this SNP and CSA (r=0.10, P=0.0008) as well as a
link between CSA and suicide attempts (r=0.17, P=0.0001) after
controlling for the covariate effects. After entering CSA in the
regression model, the link between the OATL1 SNP and suicide
attempt dropped (OR=1.66, CI 1.09–2.51**). A Sobel test
indicated significant (partial) mediation (Sobel statistic: z=2.73,
P=0.0064; Goodman statistic z=2.77, P=0.0056). Parental
suicide attempts were linked to CSA (r=0.09, P=0.0021) and
CPA (r=0.07, P=0.0129). Although CPA was significantly linked
to suicide attempts (r=0.15, P,0.0001), it was nonsignificantly
linked to the OATL1 SNP (r=20.03, P=0.3038), making further
analyses unnecessary.
Anxiety disorders. In addition to the interaction effect of
SAT1 (rs3764885) and SMS (rs6654100) described above, one SNP
(SMS, rs5951676) made a statistically significant contribution to
anxiety disorders (OR=2.05), independently of the nonsignificant
effect of parental anxiety disorders (OR=1.05) and the significant
effect of history of psychopathology (OR=1.14). Neither CSA nor
CPA demonstrated mediating effects for anxiety disorders.
Candidate endophenotypes. Externalizing (disruptiveness)
symptoms were significantly linked to mood disorders (r=0.16,
P,0.0001), anxiety disorders (r=0.09, P=0.0024), and suicide
attempts (r=0.21, P,0.0001). Disruptiveness was also linked to
the OATL1 SNP rs11795513 (r=0.09, P=0.0042) that was linked
to suicide attempts (see Table 3). After entering disruptiveness in
the regression model predicting suicide attempts, the relationship
between the OATL1 SNP and the outcome dropped (OR=1.71,
CI 1.13–2.59**). A Sobel test indicated significant (partial)
mediation (Sobel statistic: z=2.25, P=0.0244; Goodman
statistic z=2.30, P=0.0215). Disruptiveness did not demonstrate
mediating effects with respect to mood disorders or anxiety
disorders, although it was significantly linked to rs3764885 (SAT1)
(r=20.09, P=0.0009) which predicted anxiety disorders and
mood disorders.
Neither of the internalizing endophenotypes demonstrated
mediating effects with respect to any of the three outcomes.
Discussion
In this study, we examined the relationships between genetic
variants in polyamine genes and three main outcomes: suicide
attempts, mood disorders, and anxiety disorders. In addition, we
assessed the gene-gene and gene-environment interactions as well
as investigated the involvement of several potential endopheno-
types as mediators for our genetic effects. Overall, not only did
each of the four genes examined demonstrate significant
associations with at least one of our main outcomes, but each of
these outcomes was in turn associated with polyaminergic variants.
Among the genes examined, SAT1 displayed the greatest range
of effects, with polymorphisms demonstrating significant associa-
tions with each of the three main outcomes. The SAT1 gene
Table 3. Main and interactive effects for single nucleotide polymorphisms (SNP) and adult outcomes of mood disorders, suicide
attempts, and anxiety disorders.
Phenotype Gene SNP Effects, CI Covariates OR, 95%, CI
Mood disorders
Model information
D SAT1 rs3764885 0.01, 20.02–0.05 Parental mood disorder 0.05, 0.01–0.10
**
Omnibus test: x
2
(n=1121, 5)=87.14
*** History of psychopathology
A 0.07, 0.05–0.10
***
Nagelkerke R
2=0.16 CPA 0.00, 20.03–0.04
SAT1 rs3764885 X CPA 0.10, 0.01–0.19
*
Suicide attempts
Model information OATL1 rs11795513 1.80, 1.20–2.71
** Parental suicide attempt 3.52, 1.84–6.72
***
Omnibus test: x
2
(n=1121, 3)=80.68
*** History of psychopathology
B 2.74, 2.12–3.55
***
Hosmer-Lemeshow test: x
2
(3)=2.15, p=0.54
Nagelkerke R
2=0.14
Anxiety disorders
Model information SMS rs5951676 1.96, 1.21–3.17** Parental anxiety disorder 1.49, 0.91–2.45
Omnibus test: x
2
(n=1121, 6)=81.27
*** SAT1 rs3764885 0.39, 0.29–0.77** History of psychopathology
C 2.03, 1.67–2.46***
Hosmer-Lemeshow test: x
2
(4)=3.76, p=0.44 SMS rs6654100 0.34, 0.17–0.67**
Nagelkerke R
2=0.11 SAT1 X SMS rs3764885 X rs6654100 5.39, 1.11–26.20*
Effects and 95% confidence intervals (CI) are shown for each phenotype. Effects for mood disorders are represented by unstandardized regression coefficients, while
effects for suicide attempts and anxiety disorders are represented by odds ratios.
AAnxiety, disruptive and substance abuse disorders, and suicide attempts.
BAnxiety, disruptive, mood and substance abuse disorders.
CMood, disruptive and substance abuse disorders, and suicide attempts.
DAdditive model.
P-values:
*=0.05–0.01 inclusive,
**=0.0099–0.001 inclusive,
***,0.001.
doi:10.1371/journal.pone.0015146.t003
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has provided the most compelling evidence for the involvement of
dysregulated polyamine catabolism in psychiatric conditions,
particularly in completed suicide where it displays widespread
decreases in expression across the brain [21,22,24,25]. In the
present study, three SAT1 SNPs, rs6526342, rs3764885, and
rs1894289, demonstrated significant associations with the main
outcomes; interestingly however, our results indicate disease-
specificity with respect to the risk alleles at these polymorphisms.
Indeed, while rs6526342 and rs3764885 were significantly
associated with both mood and anxiety disorders, the major
alleles at these SNPs represented the risk alleles in anxiety
disorders, whereas the minor alleles conferred susceptibility
towards mood disorders. Both these SNPs, as well as two other
polymorphisms, rs6151267 and rs1960264, are found on the same
haplotype block [31], and greater proportions of the major
haplotype at this locus have been associated with both completed
suicide and anxiety disorders [21,28,29]. Interestingly, the
association of rs6151267 with completed suicide was only found
when comparing individuals with depressive disorders, indicating
that the risk conferred by this polymorphism is specific to suicide
performed in the context of depression. The results of the present
study may thus help explain this effect, as it could be that the
ability of this haplotype to confer susceptibility to suicide may have
been more apparent in a sample in which the opposite allele is
found at higher proportions. At the molecular level, we recently
characterized the role of this haplotype in influencing the
expression of SAT1, and found that the more common haplotype
was associated with lower gene expression in vitro and in the brain
[31]. Accordingly, it could be speculated that the relationships
between these SNPs and mood and anxiety disorders are mediated
by the effects of this haplotype on gene expression. Another SAT1
SNP, rs1894289, also possessed disease-specific risk alleles in terms
of its associations with attempted suicide and mood disorders.
Given that this SNP is located approximately 3.5 kb downstream
of SAT1, it is unlikely that it possesses a functional role, and rather
is tagging the functional variant. Compared to the other SAT1
SNPs examined, the linkage disequilibrium between this SNP and
others on the haplotype block is much lower: it is therefore quite
possible that this SNP is tagging an adjacent haplotype block, and
that the associations of this SNP involve distinct molecular
mechanisms.
In this study, SMS, which is involved in spermine biosynthesis,
demonstrated strong associations with anxiety disorders through
both main genetic effects as well as through a gene-gene
interaction with SAT1. Although our previous results had
indicated that this gene demonstrates altered expression in the
hippocampus of suicide completers [22], this represents the first
study indicating that it may also be involved in anxiety. We
recently characterized genetic and epigenetic factors in the
promoter region of SMS and found no indication that promoter
variants, DNA methylation, or chromatin modifications played a
role in determining the expression of this gene [59]. However, as
all of our significant associations in the present study map to
introns or regions downstream from SMS, these results may
indicate that genetic variants outside of the promoter region could
influence the expression of this gene. Alternatively, the functional
variants responsible for the associations with anxiety may influence
later gene regulatory steps, such as mRNA processing or
enzymatic activity. Indeed, several rare mutations in SMS,
resulting in altered splicing or enzymatic activity, are responsible
for Snyder-Robinson syndrome, a form of X-linked mental
retardation which manifests with both intellectual and physical
symptoms including alterations in brain morphology [60–63].
Certainly additional studies will be required to identify the variants
which are responsible for our associations as well as the
mechanisms by which they exert their effects. In addition to the
main genetic effects, we identified a gene-gene interaction between
SMS and SAT1 in conferring risk for anxiety disorders.
Interestingly, SMS and SAT1 are located in close proximity on
the X chromosome, and are at a chromosomal region which was
recently found to be associated with suicide [64]. This could
indicate the involvement of shared regulatory mechanisms, which
may be involved in the interactive effects between SNPs in these
two genes.
Unlike the other genes included in this study, the significant
findings regarding SMOX and mood disorders were only
apparent in the subset of individuals who had experienced
physical abuse in childhood. Within this subgroup, three SNPs,
two within the third intron and one located 3 kb downstream,
demonstrated significant associations with mood disorders. Along
with SMS, we recently examined genetic and epigenetic elements
in the SMOX promoter, and found little indication that expression
of this gene was influenced through these mechanisms [59]. Aside
from our previous findings regarding altered expression of this
gene in suicide completers [25], little is known concerning the
involvement of this gene in psychiatric conditions. As such, the
mechanisms by which these SNPs may act to confer susceptibility
to mood disorders is unknown.
OATL1 yielded the strongest univariate associations in this
study, with two SNPs being significantly associated with suicide
attempts. Compared to the other genes in this study, the
relationship of OATL1 to polyamine metabolism is more distant,
and its physiological function or role in polyamine metabolism has
not been well characterized. This gene was selected for this study
due to its potential involvement in suicide, as it displays altered
expression in the hippocampus of suicide completers [22]. While
the current study appears to support its involvement in suicidal
behaviors, the mechanism by which it exerts its pathological effects
remains unclear. Indeed, the two SNPs associated with attempted
suicide map outside of the gene, with rs11795513 located
approximately 2 kb upstream and rs2249583 approximately
13 kb downstream. These SNPs are part of a larger haplotype
block on the X chromosome which encompasses several genes
[38,65], and as such, it is also possible that these associations may
be due to genes located nearby rather than OATL1.
In addition to main genetic effects and gene-gene interactions,
this study examined the role of gene-environment interactions in
conferring risk towards each of the three main outcomes, as well as
controlled for possible confounding effects of gene-environment
correlations. Our results demonstrated that exposure to either
physical or sexual abuse was associated with elevated risk for
suicide attempts, mood disorders, and anxiety disorders, however
our results indicated that sexual abuse did not moderate the
genetic associations of the polyamine genes with these outcomes.
Our results identified a significant moderating effect of physical
abuse on the association between the SAT1 SNP rs3764885 and
mood disorders. Particularly interesting is that while higher levels
of the minor allele were associated with mood disorders in the
univariate analyses, the effects of physical abuse were to increase
the risk for mood disorders in individuals carrying the major allele.
Finally, we identified several evocative gene-environment correla-
tions with regards to CSA and its involvement in mood disorders
and suicide attempts, however the mechanisms involved in these
effects are not clear.
Along with analyses investigating the relationship between
genetics and the environment, a growing trend in psychiatric
research has been to investigate endophenotypes as a means to
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psychiatric disorders. Whereas our previous findings demonstrated
that externalizing and internalizing trajectories measured in
childhood were not suitable endophenotypes for mood disorders
or suicidal behaviors [36,37], the present study demonstrates that
measurement of these symptoms at an older age may be more
appropriate for describing suicidal behaviors. The ability of
externalizing behaviors to act as an endophenotype to explain
the relationship between our genetic findings and suicide attempts
agrees well with the strong association between impulsive
aggression and suicidal behaviors [15]. In addition, these results
agree with our previous findings that trajectories based upon
disruptiveness demonstrate a stronger relationship with suicide
attempts than those derived from measures of anxiousness [37].
We found no evidence that our externalizing or internalizing
endophenotypes mediate the relationships between our genetic
findings and mood or anxiety disorders. This may reflect a lack of
statistical power in our sample to detect these effects, or
alternatively, these relationships may be mediated by other
personality measures.
There are several potential limitations to this study. Although
we removed perfectly correlated SNPs from our analyses in order
to reduce statistical corrections, it is clear that many of the
remaining SNPs were highly correlated. As such, we likely
overcorrected for multiple testing in using the Benjamini–
Hochsberg procedure and may have missed additional weaker
associations. Moreover, as with all studies of this nature, the
presence of linkage disequilibrium prevents us from conclusively
identifying the functional variants nor the mechanisms by which
they exert their effects. Additionally, our statistical power to
characterize genetic effects in the smaller CPA and CSA
subsamples was limited and may have prevented us from
identifying gene-environment interactions. Also, as CSA and
CPA were assessed by self-report, recall bias may have affected
these measurements. Finally, as we did not correct our interaction
analyses for multiple testing, these findings should thus be
interpreted with caution, as they are in need of replication.
In conclusion, this study identified a number of genetic and
environmental variables associated with attempted suicide, mood
disorders, and anxiety disorders. While the precise biological
mechanisms by which these genetic variants confer risk to these
disorders remains to be determined, these studies have greatly
extended our knowledge regarding the involvement of dysregu-
lated polyamine metabolism in the etiology and pathology of
psychiatric conditions.
Supporting Information
Figure S1 Linkage disequilibrium (r
2) between poly-
morphisms within each gene.
(DOC)
Table S1 Single nucleotide polymorphisms genotyped in
each gene. Major and minor alleles are shown for each variant.
(DOC)
Table S2 Power analyses for association testing with
mood disorders in the total sample and the subgroup of
individuals exposed to childhood physical abuse (CPA),
under the assumption of an interaction between geno-
type and CPA. Tests were computed under the dominant
genetic model by combining carriers (homozygotes and heterozy-
gotes) of the risk allele. Power calculations were assessed for a
levels corresponding to false discovery rates (FDR) of 0.2.
(DOC)
Table S3 Power analyses for regression analyses of the
interaction between a genotype and childhood physical
abuse (CPA) on mood disorders. Tests were computed under
the dominant genetic model by combining carriers (homozygotes
and heterozygotes) of the risk allele. Power calculations were
assessed for a=0.05.
(DOC)
Acknowledgments
We would like to thank the subjects and their families for their participation
in this study.
Author Contributions
Conceived and designed the experiments: LMF BW FV RET AB GT.
Performed the experiments: LMF BW VJ JC AB. Analyzed the data: LMF
BW VJ JC AB. Wrote the paper: LMF BW AB GT.
References
1. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, et al. (2009) The
global burden of mental disorders: An update from the WHO World Mental
Health (WMH) Surveys. Epidemiologia e Psichiatria Sociale-An International
Journal for Epidemiology and Psychiatric Sciences 18: 23–33.
2. Kim C, Lesage A, Seguin M, Chawky N, Vanier C, et al. (2003) Patterns of co-
morbidity in male suicide completers. Psychol Med 33: 1299–1309.
3. Arsenault-Lapierre G, Kim C, Turecki G (2004) Psychiatric diagnoses in 3275
suicides: a meta-analysis. BMC Psychiatry 4: 37.
4. McGirr A, Paris J, Lesage A, Renaud J, Turecki G (2007) Risk factors for suicide
completion in borderline personality disorder: a case-control study of cluster B
comorbidity and impulsive aggression. J Clin Psychiatry 68: 721–729.
5. McGirr A, Turecki G (2008) What is specific to suicide in schizophrenia
disorder? Demographic, clinical and behavioural dimensions. Schizophr Res 98:
217–224.
6. Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, et al. (2008) Suicide and
suicidal behavior. Epidemiol Rev 30: 133–154.
7. Levinson DF (2006) The genetics of depression: a review. Biol Psychiatry 60:
84–92.
8. McGuffin P, Marusic A, Farmer A (2001) What can psychiatric genetics offer
suicidology? Crisis 22: 61–65.
9. Statham DJ, Heath AC, Madden PA, Bucholz KK, Bierut L, et al. (1998)
Suicidal behaviour: an epidemiological and genetic study. Psychol Med 28:
839–855.
10. Fu Q, Heath AC, Bucholz KK, Nelson EC, Glowinski AL, et al. (2002) A twin
study of genetic and environmental influences on suicidality in men. Psychol
Med 32: 11–24.
11. Mosing MA, Gordon SD, Medland SE, Statham DJ, Nelson EC, et al. (2009)
Genetic and Environmental Influences on the Co-Morbidity Between Depres-
sion, Panic Disorder, Agoraphobia, and Social Phobia: A Twin Study. Depress
Anxiety 26: 1004–1011.
12. Weissman MM, Wickramaratne P, Nomura Y, Warner V, Verdeli H, et al.
(2005) Families at high and low risk for depression - A 3-generation study. Arch
Gen Psychiatry 62: 29–36.
13. McGirr A, Alda M, Seguin M, Cabot S, Lesage A, et al. (2009) Familial
Aggregation of Suicide Explained by Cluster B Traits: A Three-Group Family
Study of Suicide Controlling for Major Depressive Disorder. Am J Psychiatry
166: 1124–1134.
14. Kim CD, Seguin M, Therrien N, Riopel G, Chawky N, et al. (2005) Familial
aggregation of suicidal behavior: a family study of male suicide completers from
the general population. Am J Psychiatry 162: 1017–1019.
15. Turecki G (2005) Dissecting the suicide phenotype: the role of impulsive-
aggressive behaviours. J Psychiatry Neurosci 30: 398–408.
16. Brezo J, Klempan T, Turecki G (2008) The genetics of suicide: a critical review
of molecular studies. Psychiatr Clin North Am 31: 179–203.
17. Turecki G, Sequeira A, Gingras Y, Seguin M, Lesage A, et al. (2003) Suicide and
serotonin: Study of variation at seven serotonin receptor genes in suicide
completers. Am J Med Genet B Neuropsychiatr Genet 118B: 36–40.
18. Fiori LM, Turecki G (2008) Implication of the polyamine system in mental
disorders. J Psychiatry Neurosci 33: 102–110.
19. Seiler N, Raul F (2005) Polyamines and apoptosis. J Cell Mol Med 9: 623–642.
20. Reis DJ, Regunathan S (2000) Is agmatine a novel neurotransmitter in brain?
Trends Pharmacol Sci 21: 187–193.
Polyamine Variants in Psychiatric Disorders
PLoS ONE | www.plosone.org 8 November 2010 | Volume 5 | Issue 11 | e1514621. Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, et al. (2006)
Implication of SSAT by gene expression and genetic variation in suicide and
major depression. Arch Gen Psychiatry 63: 35–48.
22. Sequeira A, Klempan T, Canetti L, Ffrench-Mullen J, Benkelfat C, et al. (2007)
Patterns of gene expression in the limbic system of suicides with and without
major depression. Mol Psychiatry 12: 640–655.
23. Guipponi M, Deutsch S, Kohler K, Perroud N, Le Gal F, et al. (2009) Genetic
and epigenetic analysis of SSAT gene dysregulation in suicidal behavior.
Am J Med Genet B Neuropsychiatr Genet 150B: 799–807.
24. Klempan TA, Rujescu D, Merette C, Himmelman C, Sequeira A, et al. (2009)
Profiling brain expression of the spermidine/spermine N(1)-acetyltransferase 1
(SAT1) gene in suicide. Am J Med Genet B Neuropsychiatr Genet 150B:
934–943.
25. Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, et al. (2009) Altered
expression of genes involved in ATP biosynthesis and GABAergic neurotrans-
mission in the ventral prefrontal cortex of suicides with and without major
depression. Mol Psychiatry 14: 175–189.
26. Gaiteri C, Guilloux JP, Lewis DA, Sibille E (2010) Altered gene synchrony
suggests a combined hormone-mediated dysregulated state in major depression.
PLoS ONE 5: e9970.
27. Chen GG, Fiori LM, Moquin L, Gratton A, Mamer O, et al. (2010) Evidence of
Altered Polyamine Concentrations in Cerebral Cortex of Suicide Completers.
Neuropsychopharmacology 35: 1477–1484.
28. Fiori LM, Turecki G (2009) Association of the SAT1 In/del Polymorphism with
Suicide Completion. Am J Med Genet B Neuropsychiatr Genet 153B: 825–829.
29. Vaquero-Lorenzo C, Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Diaz-
Hernandez M, Lopez-Castroman J, et al. (2009) Positive association between
SAT-1 -1415T/C polymorphism and anxiety. Am J Med Genet B Neuropsy-
chiatr Genet 150B: 515–519.
30. Bermudo-Soriano CR, Vaquero-Lorenzo C, Diaz-Hernandez M, Perez-
Rodriguez MM, Fernandez-Piqueras J, et al. (2009) SAT-1 -1415T/C
polymorphism and susceptibility to schizophrenia. Prog Neuropsychopharmacol
Biol Psychiatry 33: 345–348.
31. Fiori LM, Mechawar N, Turecki G (2009) Identification and Characterization of
SAT1 Promoter Variants in Suicide Completers. Biol Psychiatry 66: 460–467.
32. Gilad GM, Gilad VH (2003) Overview of the brain polyamine-stress-response:
regulation, development, and modulation by lithium and role in cell survival.
Cell Mol Neurobiol 23: 637–649.
33. Brezo J, Paris J, Barker ED, Tremblay R, Vitaro F, et al. (2007) Natural history
of suicidal behaviors in a population-based sample of young adults. Psychol Med
37: 1563–1574.
34. Brezo J, Paris J, Vitaro F, Hebert M, Tremblay RE, et al. (2008) Predicting
suicide attempts in young adults with histories of childhood abuse. Br J Psychiatry
193: 134–139.
35. Fergusson DM, Woodward LJ, Horwood LJ (2000) Risk factors and life
processes associated with the onset of suicidal behaviour during adolescence and
early adulthood. Psychol Med 30: 23–39.
36. Brezo J, Bureau A, Merette C, Jomphe V, Barker ED, et al. (2009) Differences
and similarities in the serotonergic diathesis for suicide attempts and mood
disorders: a 22-year longitudinal gene-environment study. Mol Psychiatry.
37. Brezo J, Barker ED, Paris J, Hebert M, Vitaro F, et al. (2008) Childhood
Trajectories of Anxiousness and Disruptiveness as Predictors of Suicide
Attempts. Arch Pediatr Adolesc Med 162: 1015–1021.
38. The International HapMap Consortium (2003) The International HapMap
Project. Nature 426: 789–796.
39. de Bakker PIW, Yelensky R, Pe’er I, Gabriel SB, Daly MJ, et al. (2005)
Efficiency and power in genetic association studies. Nat Genet 37: 1217–1223.
40. Straus MA (1979) Measuring Intrafamily Conflict and Violence: The Conflict
Tactics (CT) Scales. J Marriage Fam 41: 75–88.
41. Straus MA, Hamby SL, BoneyMcCoy S, Sugarman DB (1996) The revised
Conflict Tactics Scales (CTS2) - Development and preliminary psychometric
data. J Fam Issues 17: 283–316.
42. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, et al. (1998)
Relationship of childhood abuse and household dysfunction to many of the
leading causes of death in adults - The adverse childhood experiences (ACE)
study. Am J Prev Med 14: 245–258.
43. Tremblay RE, Loeber R, Gagnon C, Charlebois P, Larivee S, et al. (1991)
Disruptive Boys with Stable and Unstable High Fighting Behavior Patterns
During Junior Elementary-School. J Abnorm Child Psychol 19: 285–300.
44. Blishen BR, Carroll WK, Moore C (1987) The 1981 Socioeconomic Index for
Occupations in Canada. Canadian Review of Sociology and Anthropology-
Revue Canadienne de Sociologie et D Anthropologie 24: 465–488.
45. Breton JJ, Bergeron L, Valla JP, Berthiaume C, St Georges M (1998) Diagnostic
Interview Schedule for Children (DISC-2.25) in Quebec: reliability findings in
light of the MECA study. J Am Acad Child Adolesc Psychiatry 37: 1167–1174.
46. Robins LN, Helzer JE, Ratcliff KS, Seyfried W (1982) Validity of the Diagnostic
Interview Schedule, .2. Dsm-Iii Diagnoses. Psychol Med 12: 855–870.
47. Beck RW, Morris JB, Beck AT (1974) Cross-Validation of Suicidal-Intent-Scale.
Psychological Reports 34: 445–446.
48. Simard LR, Prescott G, Rochette C, Morgan K, Lemieux B, et al. (1994)
Linkage disequilibrium analysis of childhood-onset spinal muscular atrophy
(SMA) in the French-Canadian population. Hum Mol Genet 3: 459–463.
49. Heyer E, Tremblay M (1995) Variability of the Genetic Contribution of Quebec
Population Founders Associated to Some Deleterious Genes. Am J Hum Genet
56: 970–978.
50. Fisher SA, Lewis CM, Wise LH (2001) Detecting population outliers and null
alleles in linkage data: Application to GAW12 asthma studies. Genet Epidemiol
21: S18–S23.
51. Efron B (2004) Large-scale simultaneous hypothesis testing: The choice of a null
hypothesis. J Am Stat Assoc 99: 96–104.
52. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate - A
Practical and Powerful Approach to Multiple Testing. J R Stat Soc
Series B Methodol 57: 289–300.
53. Rinaldo A, Bacanu SA, Devlin B, Sonpar V, Wasserman L, et al. (2005)
Characterization of multilocus linkage disequilibrium. Genet Epidemiol 28:
193–206.
54. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score
tests for association between traits and haplotypes when linkage phase is
ambiguous. Am J Hum Genet 70: 425–434.
55. Dudbridge F (2003) Pedigree disequilibrium tests for multilocus haplotypes.
Genet Epidemiol 25: 115–121.
56. McClelland GH, Judd CM (1993) Statistical Difficulties of Detecting
Interactions and Moderator Effects. Psychol Bull 114: 376–390.
57. Holmbeck GN (2002) Post-hoc probing of significant moderational and
mediational effects in studies of pediatric populations. J Pediatr Psychol 27:
87–96.
58. Baron RM, Kenny DA (1986) The Moderator Mediator Variable Distinction in
Social Psychological-Research - Conceptual, Strategic, and Statistical Consid-
erations. J Pers Soc Psychol 51: 1173–1182.
59. Fiori LM, Turecki G (2010) Genetic and Epigenetic Influences on Expression of
Spermine Synthase and Spermine Oxidase in Suicide Completers.
Int J Neuropsychopharmacol 13: 725–736.
60. Cason AL, Ikeguchi Y, Skinner C, Wood TC, Holden KR, et al. (2003) X-linked
spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome.
Eur J Hum Genet 11: 937–944.
61. de Alencastro G, McCloskey DE, Kliemann SE, Maranduba CM, Pegg AE,
et al. (2008) New SMS mutation leads to a striking reduction in spermine
synthase protein function and a severe form of Snyder-Robinson X-linked
recessive mental retardation syndrome. J Med Genet 45: 539–543.
62. Kesler SR, Schwartz C, Stevenson RE, Reiss AL (2009) The impact of spermine
synthase (SMS) mutations on brain morphology. Neurogenetics 10: 299–305.
63. Becerra-Solano LE, Butler J, Castaneda-Cisneros G, McCloskey DE, Wang X,
et al. (2009) A missense mutation, p.V132G, in the X-linked spermine synthase
gene (SMS) causes Snyder-Robinson syndrome. Am J Med Genet A 149A:
328–335.
64. Fiori LM, Zouk H, Himmelman C, Turecki G (2009) X Chromosome and
Suicide. Mol Psychiatry. In press.
65. De La Vega FM, Isaac HI, Scafe CR (2006) A tool for selecting SNPs for
association studies based on observed linkage disequilibrium patterns. Pac Symp
Biocomput 487–498.
Polyamine Variants in Psychiatric Disorders
PLoS ONE | www.plosone.org 9 November 2010 | Volume 5 | Issue 11 | e15146